Nagendra Babu Indurti, MBBS

Nagendra Babu Indurti practices at Baton Rouge General Medical Center - Bluebonnet in Baton Rouge, Louisiana.

Nagendra Babu Indurti's NPI, 1649845009, was assigned on May 26, 2021. Nagendra Babu Indurti holds Louisiana license 341382.

Nagendra Babu Indurti's primary practice is Baton Rouge General Medical Center - Bluebonnet, at 8585 Picardy Ave, Baton Rouge, LA 70809 in East Baton Rouge Parish. The practice phone is (225) 387-7000.

Nagendra Babu Indurti's primary practice is Baton Rouge General Medical Center - Bluebonnet in Baton Rouge, Louisiana. Nagendra Babu Indurti is also affiliated with Baton Rouge General - Bluebonnet. The medical group on file is The Baton Rouge Clinic. Dmand AI also links Nagendra Babu Indurti to 2 more hospitals, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nagendra Babu Indurti practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Nagendra Babu Indurti's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nagendra Babu Indurti is licensed in Louisiana.

CMS data shows 260 Medicare services from Nagendra Babu Indurti across 4 procedure codes in 2024, for 106 Medicare patients. Medicare paid $21,177 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Nagendra Babu Indurti in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nagendra Babu Indurti's median patient age at 69, with 55% women.

In 2024, Nagendra Babu Indurti wrote 276 Medicare Part D claims for 111 patients. 85% of them were for generic drugs. CMS names the drug for 81 of them, across 5 drugs with 11 or more claims each, at $634 in total drug cost. In 2023, CMS named 87 claims across 4 drugs.

Nagendra Babu Indurti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Nagendra Babu Indurti from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $24.